Asunaprevir plus daclatasvir for the treatment of chronic hepatitis C virus infection.
Saved in:
| Title: | Asunaprevir plus daclatasvir for the treatment of chronic hepatitis C virus infection. |
|---|---|
| Authors: | Zeuli JD; Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA., Adie SK; School of Pharmacy and Health Professions, Creighton University, Omaha, Nebraska, USA., Rizza SA; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA., Temesgen Z; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA. temesgen.zelalem@mayo.edu. |
| Source: | Drugs of today (Barcelona, Spain : 1998) [Drugs Today (Barc)] 2015 Nov; Vol. 51 (11), pp. 629-43. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Clarivate Analytics Country of Publication: Spain NLM ID: 101160518 Publication Model: Print Cited Medium: Print ISSN: 1699-3993 (Print) Linking ISSN: 16993993 NLM ISO Abbreviation: Drugs Today (Barc) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
